Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

Abroad (travel likely)Recruiting

Conditions

Prognostic Biomarker · Liver Transplantation · Diagnostic Biomarker · Hepatocellular Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ghent University Hospital, Ghent, Belgium
Contact: Study coordinator (Xavier Verhelst, MD, PhD) · xavier.verhelst@uzgent.be · +32 9 332 23 71
Contact: Study coordinator (Emma Butaye) · emma.butaye@uzgent.be · +32 496 88 17 91

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation

Liver Transplant Failure · Prognostic Biomarkers

Abroad (travel likely)Recruiting

Ghent, Belgium